PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25025N0968BLOOD BANK analyzer reagents and consumables — Ortho-Clinical Diagnostics, Inc

Ortho-Clinical Diagnostics, Inc holds $57.6M across 1,615 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36C25024A0040. Recompete timing centers on the Sep 14, 2026 PoP end — agencies typically plan 12–18 months ahead.

250-Network Contract Office 10 (36C250)
Awarding office
Ortho-Clinical Diagnostics, Inc
Recipient
Sep 14, 2026
PoP end
$64K
Obligated
$431K
Potential
334516
NAICS
6640
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Ortho-Clinical Diagnostics, Inc — $90

Contract facts

Federal
Contract number36C25025N0968
Also listed as36C250-25-N-0968
Also listed as36C25024A0040-36C25025N0968
Agency250-Network Contract Office 10 (36C250)
Awarding office250-Network Contract Office 10 (36C250)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentOrtho-Clinical Diagnostics, Inc
CAGE1C0L5
UEIJG5JF2JQJ121
NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6640
Parent IDIQ / IDV36C25024A0040
Place of performanceRARITAN NJ
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startSep 15, 2025
PoP end (current)Sep 14, 2026
Obligated$64K
Current value$239K
Potential value$431K

BLOOD BANK ANALYZER, REAGENTS AND CONSUMABLES is a federal award for 250-Network Contract Office 10 (36C250) held by Ortho-Clinical Diagnostics, Inc. Estimated value $431K ($64K obligated). Current period of performance ends Sep 14, 2026. Place of performance: RARITAN NJ.

BLOOD BANK ANALYZER, REAGENTS AND CONSUMABLES

Recompete timing

Public
Expiring in 24 days

Current PoP ends Sep 14, 2026 (24 days remaining). Agencies typically plan 12–18 months ahead — at 0.8 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Ortho-Clinical Diagnostics, Inc$57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($57.6M) · all agencies
Department of Veterans Affairs (VA)$26.2M · 45%Department of Defense (DOD)$22.1M · 38%Department of Health and Human Services (HHS)$8.6M · 15%General Services Administration (GSA)$297K · 1%
Open full company profile

Related awards

Same parent · incumbent
75H71024F80169
FY2024 LAB VITROS7600 REAGENTS/SUPPLIES TO BE ORDERED ON AN "AS NEEDED" BASIS, PART OF CPT…
$2.1M
Aug 31, 2026
FA466121F0075
VITROS CHEMICAL ANALYZER MAINTENANCE AND CALIBRATION
$336K
Aug 31, 2026
36C25925N0518
BLOOD BANK GEL ANALYZER COST PER TEST - SLC
$114K
Sep 6, 2026
FA489721F0042
CHEM ANALYZER SERVICES - EXERCISE OPTION YEAR 1
$717K
Sep 29, 2026
36C26225N1061
BLOOD BANK AUTOMATION CPT SOLUTION
$493K
Sep 29, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C25025N0968?

36C25025N0968 (BLOOD BANK analyzer reagents and consumables) is a 250-Network Contract Office 10 (36C250) award with a potential value of $431K, currently held by Ortho-Clinical Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C250-25-N-0968?

36C250-25-N-0968 is the dashed form of PIID 36C25025N0968 (BLOOD BANK analyzer reagents and consumables), held by Ortho-Clinical Diagnostics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25025N0968?

250-Network Contract Office 10 (36C250) awarded 36C25025N0968 to Ortho-Clinical Diagnostics, Inc (potential $431K).

Who is the incumbent on 36C25025N0968?

Ortho-Clinical Diagnostics, Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Sep 14, 2026.

When does Ortho-Clinical Diagnostics, Inc’s 36C25025N0968 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 14, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C25025N0968